Organizational Chart of Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company
Decision makers at Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company by function
Human resources
-
Senior Vice President People & Culture VPj@lilly.comGet the verified email
Other functions
-
Vice President, Discovery and Translational Sciences VPr@lilly.comGet the verified email
-
Director - Clinical Supply Chain Planning (rlts) Directorst@lilly.comGet the verified email
-
Director, Environmental Health and Radiation Safety Directorsm@lilly.comGet the verified email
-
Sr. Director Clinical Supply Chain Directorsf@lilly.comGet the verified email
Decision makers at Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company
Funding and news at Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company
Funding
| Last round | Other · $125M |
|---|---|
| Total funding | $145M (3 rounds) |
Team Structure headcount by department
How to prospect Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company's departments
Research
With 9 people, this is the organisation's biggest team. Long cycles and rigorous methods: respect their pace and bring evidence, not hype.
Operations
With 8 people, this is the organisation's second pillar. Pitch measurable time savings and error reduction: the metrics this function is judged on.
Technical
This department counts 7 people. Developer experience and integration effort will make or break your pitch here.
Medical
3 people work in this department. Medical teams trust peer references: name comparable organisations you already serve.
Other
A team of 3 people. A cross-functional team where use cases vary: qualify the actual roles before tailoring your pitch.
Consulting
This department counts 2 people. These profiles sell advice for a living: come with a sharp point of view, not a generic pitch.
FAQ Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company
Who runs Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company?
The highest-ranking leadership role identified at Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company is “Senior Vice President People & Culture”, based on public data updated 18 Oct 2026.
How many decision makers does Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company have?
7 decision makers identified.
How do I contact a decision maker at Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company?
Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.
More companies to explore
Biotechnology · United States
Same group · lilly.com
About Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company
Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company is a business specialised in Biotechnology, based in United States. Founded in 2019, the company counts about 200 employees. Within the wider Hospitals and Health Care sector, Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company focuses on the Biotechnology segment. Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company sells primarily to other businesses (B2B) rather than to end consumers. To date, Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company has completed 3 funding rounds totalling $145M. Annual revenue is estimated at around $11M. Use this page to review Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company's industry, headcount, location and hiring signals, and to reach verified B2B contacts before your next outreach.
Activity & Market
Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company operates in the Biotechnology segment, part of the broader Hospitals and Health Care sector. As a B2B company, Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company primarily serves business clients and professional organisations. In terms of structure, it is registered as “Public company”.